Analysts/Institutional Investor Meet/Con. Call Updates

October 26, 2026 To, To, Listing Department, The National Stock Exchange of BSE Limited India Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Subject: Earnings Conference Call with Investor(s)/Analyst(s) – Financial Performance for Q2/H1 FY27 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith the earnings conference call invite, which will be held on Tuesday, 03rd November 2026 at 05:00 PM (IST) to discuss the unaudited financial results of the company for the quarter ended September 30, 2026. Request you to kindly take the same on record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in Anlon Healthcare Ltd Cordially invites you to its Earnings Call to discuss operational and financial performance for Q2 & H1 FY27 Tuesday, 03rd November 2026 at 05.00 PM, IST Pre-Registration Link – Click here Management will be represented by: Mr. Punit Kumar Rasadia – Chairman & Managing Director Access Numbers +91 22 6280 1488 Primary Number +91 22 7115 8869 USA: 1866 746 2133 UK: 0808 101 1573 International Toll-Free Number Singapore: 800 101 2045 Hong Kong: 800 964 448 RSVP: X-B4 Advisory – IR Rasika Sawant: +91 95944 57518 / rasika@x-b4.com Divya Shethia: +91 88505 95811 / divyashethia@x-b4.com